An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease-Reference-Cited by-同舟云学术

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

Published:2000-04-26 Issue:9 Volume:25 Page:925-930
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bolinger AM,Zangwill AB,Slattery JT,Glidden D,DeSantes K,Heyn L,Risler LJ,Bostrom B,Cowan MJ

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702371.pdf

Reference21 articles.

1. Tutschka PJ, Santos GW . Bone marrow transplantation in the busulfan-treated rat: relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients Transplantation 1977 24: 52–62

2. Santos GW, Tutschka PJ . Marrow transplantation in the busulfan treated rat: preclinical model of aplastic anemia J Natl Cancer Inst 1974 53: 1781–1785

3. Peters WP, Henner WB, Growchow LB et al. Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors Cancer Res 1987 47: 6402–6406

4. Grochow LB, Krivit W, Whitley CB, Blazer BR . Busulfan disposition in children Blood 1990 75: 1723–1727

5. Hassan M, Oberg G, Bekassy AN et al. Pharmacokinetics of high dose busulphan in relation to age and chronopharma-cology Cancer Chemother Pharmacol 1991 28: 130–134

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test‐Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients;The Journal of Clinical Pharmacology;2023-06-09

2. Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations;Therapeutic Drug Monitoring;2023-05-12

3. Significance of therapeutic dose monitoring of busulfan and targeted dose adjustment in transplantation;Japanese Journal of Transplantation and Cellular Therapy;2023

4. Could (should) we abandon total body irradiation for conditioning in children with leukemia;Blood Reviews;2022-11

5. Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease;Journal of Clinical Medicine;2022-07-03